Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Currently, a humanized anti-4-1BB is in clinical trials in patients with solid tumors, including melanoma, renal carcinoma, and ovarian cancer, and so far seems to have a favorable toxicity profile.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP316007.RAyuT71K_OYc4yn6ygwRuNih3ihq2qXdyZ049w6ha7of0130_assertion description "[Currently, a humanized anti-4-1BB is in clinical trials in patients with solid tumors, including melanoma, renal carcinoma, and ovarian cancer, and so far seems to have a favorable toxicity profile.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP316007.RAyuT71K_OYc4yn6ygwRuNih3ihq2qXdyZ049w6ha7of0130_provenance.
• NP782664.RAAT3BqMnBmazparQkfwXIisAvcNQ48zeR9ByeN6NYgH4130_assertion description "[Currently, a humanized anti-4-1BB is in clinical trials in patients with solid tumors, including melanoma, renal carcinoma, and ovarian cancer, and so far seems to have a favorable toxicity profile.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP782664.RAAT3BqMnBmazparQkfwXIisAvcNQ48zeR9ByeN6NYgH4130_provenance.
• NP382072.RAZ-rIx_s-ISFJcl9jMgwDvTcZG4ft2chcKmj5YG4r3ns130_assertion description "[Currently, a humanized anti-4-1BB is in clinical trials in patients with solid tumors, including melanoma, renal carcinoma, and ovarian cancer, and so far seems to have a favorable toxicity profile.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP382072.RAZ-rIx_s-ISFJcl9jMgwDvTcZG4ft2chcKmj5YG4r3ns130_provenance.
• NP439049.RAwbWcy7RFw4hWq1_CQZGW9tV9gvjcv5TS0mswqOiXJiI130_assertion description "[Currently, a humanized anti-4-1BB is in clinical trials in patients with solid tumors, including melanoma, renal carcinoma, and ovarian cancer, and so far seems to have a favorable toxicity profile.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP439049.RAwbWcy7RFw4hWq1_CQZGW9tV9gvjcv5TS0mswqOiXJiI130_provenance.
• NP869310.RAzwzC0KVjdF1BAGUcY9gsetKQ8jvPEObU_uptclp9yPE130_assertion description "[Currently, a humanized anti-4-1BB is in clinical trials in patients with solid tumors, including melanoma, renal carcinoma, and ovarian cancer, and so far seems to have a favorable toxicity profile.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869310.RAzwzC0KVjdF1BAGUcY9gsetKQ8jvPEObU_uptclp9yPE130_provenance.
• NP507486.RAX-_0u1byWbTTtr_FcXG37F6eUNEgRIUmr0KNkTp32sA130_assertion description "[Currently, a humanized anti-4-1BB is in clinical trials in patients with solid tumors, including melanoma, renal carcinoma, and ovarian cancer, and so far seems to have a favorable toxicity profile.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP507486.RAX-_0u1byWbTTtr_FcXG37F6eUNEgRIUmr0KNkTp32sA130_provenance.
• assertion description "[Currently, a humanized anti-4-1BB is in clinical trials in patients with solid tumors, including melanoma, renal carcinoma, and ovarian cancer, and so far seems to have a favorable toxicity profile.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Currently, a humanized anti-4-1BB is in clinical trials in patients with solid tumors, including melanoma, renal carcinoma, and ovarian cancer, and so far seems to have a favorable toxicity profile.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP977396.RAd8MWHzUIz8P9nGHSrzHWKUw7xJxZJ2m2UnRuWPJrnAY130_assertion description "[Currently, a humanized anti-4-1BB is in clinical trials in patients with solid tumors, including melanoma, renal carcinoma, and ovarian cancer, and so far seems to have a favorable toxicity profile.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP977396.RAd8MWHzUIz8P9nGHSrzHWKUw7xJxZJ2m2UnRuWPJrnAY130_provenance.
• NP977398.RAC3WBZnZfHHUgl9YanPVM20NQFIYvFT4XJtcWJpGJ5Iw130_assertion description "[Currently, a humanized anti-4-1BB is in clinical trials in patients with solid tumors, including melanoma, renal carcinoma, and ovarian cancer, and so far seems to have a favorable toxicity profile.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP977398.RAC3WBZnZfHHUgl9YanPVM20NQFIYvFT4XJtcWJpGJ5Iw130_provenance.
• NP507465.RAlcPBrRdO-DEBPMBaPkMolONA8DoNDfnUP4VEoKUxTws130_assertion description "[Currently, a humanized anti-4-1BB is in clinical trials in patients with solid tumors, including melanoma, renal carcinoma, and ovarian cancer, and so far seems to have a favorable toxicity profile.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP507465.RAlcPBrRdO-DEBPMBaPkMolONA8DoNDfnUP4VEoKUxTws130_provenance.
• NP938176.RAE1E-YfeqH0UKigT5AK5SKTjc8yz3keh1dySOS9Hep74130_assertion description "[Currently, a humanized anti-4-1BB is in clinical trials in patients with solid tumors, including melanoma, renal carcinoma, and ovarian cancer, and so far seems to have a favorable toxicity profile.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP938176.RAE1E-YfeqH0UKigT5AK5SKTjc8yz3keh1dySOS9Hep74130_provenance.
• NP507474.RAKDa-Musdnnzwv7VVSscJF5aPnfMwko8IeHoPU3opNXc130_assertion description "[Currently, a humanized anti-4-1BB is in clinical trials in patients with solid tumors, including melanoma, renal carcinoma, and ovarian cancer, and so far seems to have a favorable toxicity profile.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP507474.RAKDa-Musdnnzwv7VVSscJF5aPnfMwko8IeHoPU3opNXc130_provenance.
• NP507497.RA1CqZcH5Qrq-rYT4WFcTkmCm9k4bUM_i5iqM_Cd7MYRg130_assertion description "[Currently, a humanized anti-4-1BB is in clinical trials in patients with solid tumors, including melanoma, renal carcinoma, and ovarian cancer, and so far seems to have a favorable toxicity profile.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP507497.RA1CqZcH5Qrq-rYT4WFcTkmCm9k4bUM_i5iqM_Cd7MYRg130_provenance.
• NP977395.RA6rYc7bgmqnSn9hEL-DTuo9oXng3OkO9C1iawo90I4xY130_assertion description "[Currently, a humanized anti-4-1BB is in clinical trials in patients with solid tumors, including melanoma, renal carcinoma, and ovarian cancer, and so far seems to have a favorable toxicity profile.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP977395.RA6rYc7bgmqnSn9hEL-DTuo9oXng3OkO9C1iawo90I4xY130_provenance.
• NP977397.RA2DmgAWg8wLE_VUwWPZl4Q2smWBqcMGzl0Q-OkPmN11Q130_assertion description "[Currently, a humanized anti-4-1BB is in clinical trials in patients with solid tumors, including melanoma, renal carcinoma, and ovarian cancer, and so far seems to have a favorable toxicity profile.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP977397.RA2DmgAWg8wLE_VUwWPZl4Q2smWBqcMGzl0Q-OkPmN11Q130_provenance.